Argentina vs Kazakhstan: Cause of death, by non-communicable diseases, female
Argentina
64.0%
in 2021
Kazakhstan
64.9%
in 2021
Argentina rank
111th
Kazakhstan rank
109th
Cause of death, by non-communicable diseases, female over time
- Argentina
- Kazakhstan
How they compare
Kazakhstan currently reports 64.9% against 64.0% in Argentina, a difference of 0.9%.
Across all 6 years both countries report, Kazakhstan has been ahead every year.
Argentina ranks 111th and Kazakhstan ranks 109th of 185 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82.7% | 87.1% | 4.3% | Kazakhstan |
| 2010s | 79.6% | 91.0% | 11.4% | Kazakhstan |
| 2020s | 66.5% | 70.0% | 3.5% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Argentina or Kazakhstan?
- Kazakhstan, at 64.9% against 64.0% in Argentina as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Argentina and Kazakhstan?
- 0.9%, with Kazakhstan ahead.
- How many years of comparable data are there for Argentina and Kazakhstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Argentina and Kazakhstan rank globally for cause of death, by non-communicable diseases, female?
- Argentina ranks 111th and Kazakhstan ranks 109th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.